The Oil & Gas Journal, first published in 1902, is the world's most widely read petroleum industry publication. OGJ delivers international oil and gas industry news; analysis of issues and events; practical technology for design, operation, and maintenance of oil and gas operations; and important statistics on energy markets and industry activity.

OGJ is edited to meet the needs of engineers, geoscientists, managers, and executives throughout the oil and gas industry. It is part of Endeavor Business Media, Nashville, Tenn., which also publishes Offshore Magazine.

Endeavor Business Media’s Petroleum Group also produces targeted e-Newsletters; hosts global conferences and exhibitions, seminars, and forums; and publishes directories, technical books, print and electronic databases, surveys, and maps.

Additional Information

Website & Technical Help

For help with subscription purchases or refunds, or trouble logging into the paid subscription content on www.ogj.com, please contact Customer Service at [email protected] or call 1-847-559-7598.

For more customer service information, please click here.

Spartan Capital Securities, LLC Serves as Sole Placement Agent in Virpax Pharmaceuticals, Inc.'s $5.0 Million Public Offering

New York, NY, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Spartan Capital Securities, LLC, a leading investment banking firm, is pleased to announce its role as the sole placement agent in Virpax Pharmaceuticals, Inc.'s (Nasdaq: VRPX) successful $5.0 million public offering of common stock and pre-funded warrants.

Virpax Pharmaceuticals, a preclinical-stage pharmaceutical company focused on developing novel and proprietary drug delivery systems across various pain indications, raised $5.0 million through the sale of shares of common stock and pre-funded warrants at a public offering price of $0.50 per share. The company intends to use the proceeds for ongoing activities, including its planned Investigational New Drug (IND) filing for its patented injectable “local anesthetic” liposomal technology, Probudur™, aimed at post-operative pain management. Additionally, funds will be allocated to marketing and advertising services provided by IR Agency LLC, as well as general corporate purposes.

“We are proud to have served as the sole placement agent in Virpax Pharmaceuticals’ public offering,” said John Lowry, CEO of Spartan Capital Securities. “Virpax’s innovative approach to non-opioid pain management has the potential to address critical unmet needs in post-operative pain care. We look forward to continuing to support the company’s efforts to advance its breakthrough technologies.”

Spartan Capital Securities was represented by Lucosky Brooker LLP, with Scott Linksy, Xiaofan Zhang, and Raymond Ressy serving as counsel. Virpax Pharmaceuticals was represented by Sichenzia Ross Ference Carmel LLP, with Ross Carmel and Benjamin Sklar acting as counsel.

About Spartan Capital Securities, LLC

Spartan Capital Securities, LLC is a premier full-service investment banking firm offering a comprehensive range of advisory services to institutional clients and high-net-worth individuals. Known for its expertise in capital raising, strategic advisory, and asset management, Spartan Capital delivers tailored solutions to meet clients' financial goals.

For more information about Spartan Capital Securities, visit www.spartancapital.com.

Contact:
Spartan Capital Securities, LLC
45 Broadway, 19th Floor
New York, NY 10006
investmentbanking@spartancapital.com


Primary Logo

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.